13F Data
13F filer · CIK 1856083

Deep Track Capital, LP

GREENWICH, CT · filing since Q4 2021 · last filing Aug 14, 2026
Reported value
$6.9B
+$746.9M vs prior
Positions
67
New / sold out
19 / 15
Added / reduced
22 / 15
Turnover
27.7%
buys $1.8B · sells $2.3B
Top-10 weight
39.6%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewALNYLAM PHARMACEUTICALS INC+825,000–+$248.3M
AddedVERADERMICS INC+1,500,000+300.0%+$184.4M
NewHEMAB THERAPEUTICS HLDGS INC+3,602,093–+$132.3M
AddedBIOMARIN PHARMACEUTICAL INC+2,157,481+187.6%+$123.5M
NewGH RESEARCH PLC+3,333,334–+$89.6M
NewGENMAB A/SCALL+3,000,000–+$82.4M
NewUNITED THERAPEUTICS CORP DEL+123,616–+$67.0M
NewAVALO THERAPEUTICS INC+3,610,000–+$66.7M
AddedCELLDEX THERAPEUTICS INC NEW+1,655,172+128.9%+$61.6M
NewALTIMMUNE INC+19,250,000–+$58.5M
31 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outSPDR SERIES TRUSTPUT-10,000,000-100.0%$-1.3B
Sold outAPELLIS PHARMACEUTICALS INC-4,532,374-100.0%$-182.3M
Sold outCENTESSA PHARMACEUTICALS PLC-3,158,041-100.0%$-125.4M
ReducedAXSOME THERAPEUTICS INC.-400,000-36.4%$-97.9M
ReducedIMMUNOVANT INC-2,185,820-19.0%$-84.2M
Sold outBRIDGEBIO PHARMA INC-841,445-100.0%$-62.5M
ReducedCYTOKINETICS INC-674,320-49.1%$-57.4M
Sold outTERNS PHARMACEUTICALS INC-1,073,877-100.0%$-56.6M
ReducedMBX BIOSCIENCES INC-1,025,000-37.2%$-56.6M
ReducedIMMUNOCORE HLDGS PLC-1,620,666-83.9%$-51.5M
20 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2021: $1.4BQ1 2022: $1.6BQ2 2022: $1.5BQ3 2022: $2.2BQ4 2022: $2.4BQ1 2023: $2.4BQ2 2023: $2.2BQ3 2023: $2.6BQ4 2023: $3.0BQ1 2024: $3.5BQ2 2024: $3.4BQ3 2024: $3.2BQ4 2024: $2.7BQ1 2025: $3.1BQ2 2025: $3.1BQ3 2025: $3.6BQ4 2025: $5.6BQ1 2026: $6.1BQ2 2026: $6.9B
Q4 2021Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1GUARDANT HEALTH INCCOM3,393,312$509.1M7.41%
2IMMUNOVANT INCCOM9,341,151$359.9M5.24%
3STRUCTURE THERAPEUTICS INCSPONSORED ADS4,740,072$254.4M3.70%
4VAXCYTE INCCOM4,300,000$250.0M3.64%
5ALNYLAM PHARMACEUTICALS INCCOM825,000$248.3M3.61%
6VERADERMICS INCCOMMON STOCK2,000,000$245.9M3.58%
7TARSUS PHARMACEUTICALS INCCOM3,666,768$230.8M3.36%
8NUVALENT INCCOM1,783,322$220.2M3.21%
9ALKERMES PLCSHS4,000,000$209.6M3.05%
10OCULAR THERAPEUTIX INCCOM19,686,282$193.3M2.81%
57 more rows. Subscribe for $29/month to see every row, download the data and use the API.